Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

Metadata

Authors/Creators:	Shah, V Johnson, DC Sherborne, AL Ellis, S Price, A Kendall, J Chiecchio, L Striha, A https://orcid.org/0000-0003-3363-8417 Hockaday, A Pawlyn, C Jenner, M Drayson, MT Owen, RG Gregory, WM Morgan, G Davies, FE Houlston, RS Cook, G https://orcid.org/0000-0003-0223-3652 Cairns, D https://orcid.org/0000-0002-2338-0179 Jackson, GH Kaiser, M
Keywords:	multiple myeloma, lenalidomide, thalidomide, transplantation, bortezomib, cardiovascular diseases, follow-up, genetic aspects, magnetic resonance cholangiography, neoadjuvant therapy
Dates:	Published: 29 November 2018
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	05 May 2020 11:22
Last Modified:	29 Jun 2020 13:36
Status:	Published
Publisher:	American Society of Hematology
Identification Number:	https://doi.org/10.1182/blood-2018-99-110149
Related URLs:	Author

CORE (COnnecting REpositories)